ID: ALA3594282

Max Phase: Preclinical

Molecular Formula: C13H16Br2O4

Molecular Weight: 396.08

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCCCC(=O)c1c(O)c(Br)c(OC)c(Br)c1O

Standard InChI:  InChI=1S/C13H16Br2O4/c1-3-4-5-6-7(16)8-11(17)9(14)13(19-2)10(15)12(8)18/h17-18H,3-6H2,1-2H3

Standard InChI Key:  RJQGJIDUZSJGBU-UHFFFAOYSA-N

Associated Targets(non-human)

Drosophila (190 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 396.08Molecular Weight (Monoisotopic): 393.9415AlogP: 4.39#Rotatable Bonds: 6
Polar Surface Area: 66.76Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 7.16CX Basic pKa: CX LogP: 5.64CX LogD: 5.18
Aromatic Rings: 1Heavy Atoms: 19QED Weighted: 0.55Np Likeness Score: 0.94

References

1. Nguyen VH, Kikuchi H, Kubohara Y, Takahashi K, Katou Y, Oshima Y..  (2015)  Development of novel DIF-1 derivatives that selectively suppress innate immune responses.,  23  (15): [PMID:26122773] [10.1016/j.bmc.2015.06.027]

Source